SynthesisFuture oncology (London, England)2025

Comparison of mTOR inhibitors combined with endocrine therapy versus that alone in breast cancer: a meta-analysis.

Wei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.